---
figid: PMC4455918__12990_2015_30_Fig2_HTML
figtitle: Spinal cord NMDA receptor-mediated activation of mTOR signaling in cancer
  pain
organisms:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Hylobates sp.
- Saccharomyces cerevisiae
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4455918
filename: 12990_2015_30_Fig2_HTML.jpg
figlink: /pmc/articles/PMC4455918/figure/Fig2/
number: F2
caption: 'Proposed mechanism of spinal cord NMDA receptor-mediated activation of mTOR
  signaling in cancer pain. Under normal conditions (a), magnesium blocks NMDAR activity,
  thus silencing the intracellular kinases including the mTOR signaling pathway. Under
  cancer conditions (b), cancer-caused noxious insult leads to removal of the magnesium
  from NMDA receptors, resulting in calcium influx through NMDA receptor activation.
  The influx of calcium may then activate PI3K and Akt kinases which go on to phosphorylate
  mTOR. Active mTOR phosphorylates S6K1/2 and 4E-BP1/2 leading to protein translation
  initiation. 4E-BP1/2: eIF4E-binding protein1/2. Akt: protein kinase B. mTOR: mammalian
  target of rapamycin. NMDAR: NMDA receptor; NR1: a subunit of NMDA receptors. p:
  phosphorylated. PI3K: phosphoinositide 3-kinase. S6K1/2, p70 ribosomal S6 Kinase
  1/2'
papertitle: mTOR, a new potential target for chronic pain and opioid-induced tolerance
  and hyperalgesia.
reftext: Brianna Marie Lutz, et al. Mol Pain. 2015;11:32.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9261759
figid_alias: PMC4455918__F2
figtype: Figure
redirect_from: /figures/PMC4455918__F2
ndex: d83ebf5c-df06-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4455918__12990_2015_30_Fig2_HTML.html
  '@type': Dataset
  description: 'Proposed mechanism of spinal cord NMDA receptor-mediated activation
    of mTOR signaling in cancer pain. Under normal conditions (a), magnesium blocks
    NMDAR activity, thus silencing the intracellular kinases including the mTOR signaling
    pathway. Under cancer conditions (b), cancer-caused noxious insult leads to removal
    of the magnesium from NMDA receptors, resulting in calcium influx through NMDA
    receptor activation. The influx of calcium may then activate PI3K and Akt kinases
    which go on to phosphorylate mTOR. Active mTOR phosphorylates S6K1/2 and 4E-BP1/2
    leading to protein translation initiation. 4E-BP1/2: eIF4E-binding protein1/2.
    Akt: protein kinase B. mTOR: mammalian target of rapamycin. NMDAR: NMDA receptor;
    NR1: a subunit of NMDA receptors. p: phosphorylated. PI3K: phosphoinositide 3-kinase.
    S6K1/2, p70 ribosomal S6 Kinase 1/2'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Grin1
  - Pik3r1
  - Akt1
  - Mtor
  - Rps6kb1
  - Eif4ebp1
  - Eif4ebp2
  - Il11ra1
  - Ndor1
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPS6KB1
  - EIF4EBP1
  - NDOR1
  - E(spl)mgamma-HLH
  - Nmdar2
  - Nmdar1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - caz
  - Akt
  - Tor
  - S6k
  - Thor
  - pi
  - Glu
---
